Lota S. Zoth, Cpa
board of director
Orexigen Therapeutics
Orexigen
Australia
Biography
Ms. Zoth has served as a member of our board of directors since April 2012. Ms. Zoth served as Senior Vice President and Chief Financial Officer of MedImmune, Inc. from April 2004 to July 2007 and also served as its Controller and Principal Accounting Officer. Prior to joining Medlmmune in 2002, Ms. Zoth served as Senior Vice President, Corporate Controller and Principal Accounting Officer at PSINet Inc., Vice President, Corporate Controller and Chief Accounting Officer at Sodexho Marriott Services, Inc., Marriott International and PepsiCo, Inc. Ms. Zoth also served as an auditor at Ernst & Young, LLP and is a Certified Public Accountant. Ms. Zoth is a member of the board of directors of Hyperion Therapeutics, Inc., NewLink Genetics, Inc. and two private companies. Ms. Zoth received a B.B.A. in accounting from Texas Tech University.
Research Interest
molecular biology and microbial genetics
